This Insurance Broker Has Outperformed the S&P 500 Over the Past Decade: Should You Buy It?
When it comes to underappreciated winners, Marsh & McLennan (NYSE: MMC) is one stock that has outperformed the broader market for over a decade. The insurance broker has a solid history of steady revenue growth and expense management, and investors have been rewarded as a result. Over the past 10 years, the company has provided investors with gains of more than 350% at Tuesday's prices, compared to the S&P 500's 225% during the same time period.
Marsh & McLennan is not limited to insurance brokerage. While this is a big source of revenue, the company is also a leading provider of consulting services -- helping workplaces tackle things related to health, wealth, and career management. The company is well-positioned with billions in cash it looks to put to work in order to add more value for investors. Here's what you should know about Marsh & McLennan.
Image source: Getty Images.
Source Fool.com
